COTQF Stock - Cotinga Pharmaceuticals Inc.
Unlock GoAI Insights for COTQF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | $-83,849 | $-170,676 | $-182,437 | $-172,635 | $-1,012,264 |
| Gross Margin | N/A | N/A | N/A | N/A | N/A |
| Operating Income | $-2,004,757 | $-4,930,090 | $-5,180,940 | $-3,220,669 | $-3,182,375.58 |
| Net Income | $-2,005,115 | $-3,807,007 | $-4,540,985 | $-3,931,364 | $-3,148,817.08 |
| Net Margin | N/A | N/A | N/A | N/A | N/A |
| EPS | $-0.09 | $-0.24 | $-0.31 | $-0.31 | $-0.29 |
Cotinga Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer and other unmet medical needs. The company's lead compound is COTI-2, an oral small molecule targeting p53 a tumor suppressor gene. It also develops COTI-219, an oral small molecule compound targeting the mutant forms of KRAS without inhibiting normal KRAS functions. Cotinga Pharmaceuticals Inc. has a research collaboration with St. Vincent's University Hospital to evaluate COTI-2 in combination with eribulin in patients with triple negative metastatic breast cancer. The company was formerly known as Critical Outcome Technologies Inc. and changed its name to Cotinga Pharmaceuticals Inc. in January 2018. Cotinga Pharmaceuticals Inc. is based in Toronto, Canada.
Visit WebsiteEarnings History & Surprises
COTQFEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2020 | Apr 1, 2020 | — | $-0.02 | — | — |
Q4 2019 | Dec 27, 2019 | — | $-0.02 | — | — |
Q4 2019 | Oct 30, 2019 | — | $-0.02 | — | — |
Q2 2019 | Apr 1, 2019 | — | $-0.01 | — | — |
Q4 2018 | Dec 31, 2018 | — | $-0.02 | — | — |
Q4 2018 | Oct 1, 2018 | — | $-0.03 | — | — |
Q3 2018 | Aug 28, 2018 | — | $-0.08 | — | — |
Q2 2018 | Apr 3, 2018 | $-0.11 | $-0.06 | +45.5% | ✓ BEAT |
Q4 2017 | Dec 29, 2017 | $-0.10 | $-0.09 | +10.0% | ✓ BEAT |
Q3 2017 | Sep 29, 2017 | — | $-0.02 | — | — |
Q3 2017 | Aug 28, 2017 | — | $-0.10 | — | — |
Q1 2017 | Mar 16, 2017 | $-0.10 | $-0.10 | 0.0% | = MET |
Q4 2016 | Dec 19, 2016 | $-0.10 | $-0.10 | 0.0% | = MET |
Q3 2016 | Sep 29, 2016 | $-0.10 | $-0.10 | 0.0% | = MET |
Q3 2016 | Aug 3, 2016 | — | $-0.10 | — | — |
Q1 2016 | Mar 11, 2016 | — | — | — | — |
Q4 2015 | Dec 16, 2015 | — | — | — | — |
Q3 2015 | Sep 29, 2015 | $-0.10 | $-0.10 | 0.0% | = MET |
Q3 2015 | Aug 28, 2015 | $-0.10 | $-0.10 | 0.0% | = MET |
Q1 2015 | Mar 20, 2015 | — | — | — | — |
Latest News
Frequently Asked Questions about COTQF
What is COTQF's current stock price?
What is the analyst price target for COTQF?
What sector is Cotinga Pharmaceuticals Inc. in?
What is COTQF's market cap?
Does COTQF pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to COTQF for comparison